Improving hair transplant survival for male pattern baldness
Part of Skin clinical trials.
This study tests a new, evidence-based protocol to help hair follicles survive better during a hair transplant procedure called follicular unit extraction (FUE). It may help men with male pattern baldness or scarring hair loss achieve better hair growth after the transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 60 years old.
- You have male pattern baldness (androgenetic alopecia) or a type of scarring hair loss that can be treated with hair transplant.
- You have enough hair in the donor area (usually the back of the head) for the procedure, as confirmed by a doctor.
- You have tried medical treatments like minoxidil (Rogaine) or finasteride (Propecia) for at least 6 months with little or no improvement.
- You are generally healthy and can have minor outpatient surgery under local anesthesia.
- You are willing to follow the study schedule for 12 months after the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding exosomes (tiny cell-repair particles) to a fractional laser treatment helps regrow hair more effectively than laser alone in men with common pattern baldness. If you qualify, you'll receive treatment on part of your scalp while doctors compare both approaches.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This trial tests whether injecting exosomes, tiny particles from cells, into the scalp can help regrow hair in men with common male pattern baldness. It's an early-stage study that also looks at how the treatment affects hair follicles.
This study tests whether a dietary supplement helps hair growth in men with mild to moderate male pattern baldness. It lasts 6 months, and you will not know if you are getting the real supplement or a placebo.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.